Abstract
Physiological senescence is characterized by the increasing limitation of capabilities of an organism resulting from the progressive accumulation of molecular damage, which at group (cohort) level translates into, among other things, an increase in mortality risks with age. Physiological senescence is generally thought to begin at birth, if not earlier, but models of demographic aging (i.e., an increase in mortality risks) normally start at considerably later ages. This apparent inconsistency can be solved by assuming the existence of two mortality regimes: “latent” and “manifest” aging. Up to a certain age, there is only latent aging: physiological senescence occurs, but its low level does not trigger any measurable increase in mortality. Past a certain level (and age), molecular damage is such that mortality risks start to increase. We first discuss why this transition from latent to manifest aging should exist at all, and then we turn to the empirical estimation of the corresponding threshold age by applying Bai’s approach to the estimation of breakpoints in time series. Our analysis, which covers several cohorts born between 1850 and 1938 in 14 of the countries included in the Human Mortality Database, indicates that an age at the onset of manifest aging can be identified. However, it has not remained constant: it has declined from about 43 and 47 years, respectively, for males and females at the beginning of the period (cohorts born in 1850–1869) to about 31 for both males and females toward its end (cohorts born in 1920–1938). A discussion of why this may have happened ensues.
Similar content being viewed by others
Notes
In this text, demographic aging denotes the phase when individual mortality risks accelerate irreversibly. Instead, senescence or physiological aging indicates the process characterized by the increasing limitation of capabilities of an organism due to the progressive accumulation of molecular damage.
“Variation in initial cell number and damage rate will in turn affect the time taken before a threshold for dysfunction is crossed,” according to Kirkwood and Austad (2000:237; emphasis added).
Because \( {\overline{k}}_0 \)is the mean age at which manifest (individual) aging begins, some individuals will start aging before or after \( {\overline{k}}_0 \). Thus, the aggregate (cohort) rate of aging will begin to increase some time before \( {\overline{k}}_0 \)and will continue to do so for a while after that, gradually passing from its initial level (supposedly, 0) to its final value: for instance, β = 0.1 in Vaupel’s (2010) hypothesis (see also Baudisch and Vaupel 2010). This is consistent with the empirical estimates of β made by, among others, Horiuchi (1997), Horiuchi et al. (2003), and Li et al. (2013). In short, \( {\overline{k}}_0 \)is not the age when mortality starts increasing following exactly a Gompertz pattern, with a possibly constant rate of β = 0.1.
Noisy series should therefore be treated with special caution.
Bai’s methodology works separately on the log-differentiated hazard functions of each cohort: mortality selection can be thought to operate within each cohort, but not at the group level. Note that \( \widehat{b} \) is calculated on the mean evolution of the rate of aging in each cohort and is therefore not affected by the size of cohorts, who have all the same weight in the procedure.
The distribution of the error terms, however, can be proved to be approximately normal.
Period effects can also be negative: wars and epidemics are the most relevant examples. In this context, we consider only positive period effects, such as medical breakthroughs, because we focus on mortality reduction.
The expected magnitude of the break is β S − β L = 0.1 – 0 = 0.1.
This pioneering analysis follows Finch et al.’s (1990) and Finch’s (1994) suggestion of focusing on intrinsic mortality. It may, however, suffer from a few biases because (1) it is based on period data; (2) it does not account for heterogeneity; and (3) mortality acceleration is supposed to begin when the first individuals of the (fictitious) cohort start aging.
References
Abrams, P. A. (1991). The fitness costs of senescence: The evolutionary importance of events in early adult life. Evolutionary Ecology, 5, 343–360.
Almond, D., & Mazumder, B. (2005). The 1918 influenza pandemic and subsequent health outcomes: An analysis of SIPP data. American Economic Review, 95, 258–262.
Bafitis, H., & Sargent, F. (1977). Human physiological adaptability through the life sequence. Journal of Gerontology, 32, 402–410.
Bai, J. (2010). Common breaks in means and variances for panel data. Journal of Econometrics, 157, 78–92.
Barbi, E., & Vaupel, J. W. (2005). Comment on “Inflammatory exposure and historical changes in human life-spans.” Science, 308, 1743.
Baudisch, A., & Vaupel, J. W. (2010). Senescence vs. sustenance: Evolutionary-demographic models of ageing. Demographic Research, 23(article 23), 656–668. doi:10.4054/DemRes.2010.23.23
Baudisch, A., & Vaupel, J. W. (2012). Getting to the root of aging. Science, 338, 618–619.
Beltrán-Sánchez, H., Crimmis, E. M., & Finch, C. E. (2012). Early cohort mortality predicts the cohort rate of aging: An historical analysis. Journal of Developmental Origins of Health and Disease, 3, 380–386.
Ben-Shlomo, Y., & Kuh, D. (2002). A life course approach to chronic disease epidemiology: Conceptual models, empirical challenges and interdisciplinary perspective. International Journal of Epidemiology, 31, 285–293.
Brillinger, D. R. (1986). The natural variability of vital rates and associated statistics. Biometrics, 42, 693–734.
Burger, O., Baudisch, A., & Vaupel, J. W. (2012). Human mortality improvement in evolutionary context. Proceedings of the National Academy of Sciences of the United States of America, 109, 18210–18214.
Carnes, B. A., Holden, L. R., Olshansky, S. J., Witten, T. M., & Siegel, J. S. (2006). Mortality partitions and their relevance to research on senescence. Biogerontology, 7, 183–198.
Carnes, B. A., & Olshansky, S. J. (1997). A biologically motivated partitioning of mortality. Experimental Gerontology, 32, 615–631.
Carnes, B. A., Olshansky, S. J., & Grahn, D. (2003). Biological evidence for limits to the duration of life. Biogerontology, 4, 31–45.
Carnes, B. A., Staats, D. O., & Sonntag, W. E. (2008). Does senescence give rise to disease? Mechanisms of Ageing Development, 129, 693–699.
Carnes, B. A., & Witten, T. M. (2014). How long must humans live? Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 69, 965–970.
Doblhammer, G. (2004). The late life legacy of very early life. Berlin, Heidelberg, Germany: Springer.
Dolejs, J. (1997). The extension of Gompertz law’s validity. Mechanisms of Ageing and Developments, 99, 233–244.
Finch, C. E. (1994). Longevity, senescence, and the genome. Chicago, IL: University of Chicago Press.
Finch, C. E., Beltrán-Sánchez, H., & Crimmins, E. M. (2014). Uneven futures of human lifespans: Reckonings from Gompertz mortality rates, climate change, and air pollution. Gerontology, 60, 183–188.
Finch, C. E., & Crimmins, E. M. (2004). Inflammatory exposure and historical changes in human life-spans. Science, 305, 1736–1739.
Finch, C. E., Pike, M. C., & Witten, M. (1990). Slow mortality rate accelerations during aging in some animals approximate that of humans. Science, 249, 902–905.
Fogel, R. W. (2004a). Changes in the process of aging during the twentieth century: Findings and procedures of the early indicators project. Population and Development Review, 30, 19–47.
Fogel, R. W. (2004b). The escape from hunger and premature death, 1720–2100. Europe, America and the Third World. Cambridge, UK: Cambridge University Press.
Gavrilov, L. A., & Gavrilova, N. S. (1991). The biology of life span: A quantitative approach. London, UK: Harwood Academic Publishers.
Gavrilov, L. A., & Gavrilova, N. S. (2006). Reliability theory of aging and longevity. In E. J. Masoro & S. N. Austad (Eds.), Handbook of the biology of aging (6th ed., pp. 3–42). Oxford, UK: Elsevier.
Gavrilov, L. A., & Gavrilova, N. S. (2011). Mortality measurement at advanced ages: A study of the Social Security Administration death master file. North American Actuarial Journal, 15, 432–447.
Gessert, C. E., Elliot, B. A., & Haller, I. V. (2002). Dying of old age: An examination of death certificates of Minnesota centenarians. Journal of the American Geriatrics Society, 50, 1561–1565.
Gessert, C. E., Elliot, B. A., & Haller, I. V. (2003). Letter to the Editor: Mortality patterns in middle age and old age. Journal of Gerontology, 58, 967.
Goldstein, J. R. (2011). A secular trend toward earlier male sexual maturity: Evidence from shifting ages of male young adult mortality. Plos One, 6(8), 1–5. doi:10.1371/journal.pone.0014826
Gompertz, B. (1825). On the nature of the function expressive of the law of human mortality. Phylosophical Transactions, 27, 513–519.
Gurven, M., & Kaplan, H. (2007). Longevity among hunter-gatherers. A cross-cultural examination. Population and Development Review, 33, 321–366.
Hamilton, W. D. (1966). The moulding of senescence by natural selection. Journal of Theoretical Biology, 12, 12–45.
Holliday, R. (1998). Causes of aging. Annals of the New York Academy of Sciences, 854, 61–71.
Holliday, R. (2006). Aging is no longer an unsolved problem in biology. Annals of the New York Academy of Sciences, 1067, 1–9.
Holliday, R. (2010). Aging and the decline in health. Health, 2, 615–619.
Horiuchi, S. (1997). Postmenopausal acceleration of age-related mortality increase. Journals of Gerontology, Series B: Biological Sciences and Medical Sciences, 1, B78–B92.
Horiuchi, S., & Coale, A. J. (1990). Age patterns of mortality for older women: An analysis using the age-specific rate of mortality change with age. Mathematical Population Studies, 2, 245–267.
Horiuchi, S., Finch, C. E., Meslé, F., & Vallin, J. (2003). Differential patterns of age-related mortality increase in middle age and old age. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 58, 495–507.
Horiuchi, S., & Wilmoth, J. R. (1998). Deceleration in the age pattern of mortality at older ages. Demography, 35, 391–412.
Human Mortality Database (HMD). (n.d.). University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). Retrieved from www.mortality.org or www.humanmortality.de
Jones, O. R., Gaillard, J.-M., Tuljapurkar, S., Alho, J. S., Armitage, K. B., Becker, P. H., & Coulson, T. (2008). Senescence rates are determined by ranking on the fast-slow life-history continuum. Ecology Letters, 11, 664–673.
Jones, O. R., Scheuerlein, A., Salguero-Gomez, R., Camarda, C. G., Schaible, R., Casper, B. B., & Vaupel, J. W. (2014). Diversity of ageing across the tree of life. Nature, 505, 169–174.
Kirkwood, T. B. L., & Austad, S. N. (2000). Why do we age? Nature, 409, 233–238.
Kirkwood, T. B. L., & Rose, M. R. (1991). Evolution of senescence: Late survival sacrificed for reproduction. Philosophical Transactions of the Royal Society B, 332, 15–24.
Levitis, D. A. (2010). Before senescence: The evolutionary demography of ontogenesis. Proceedings of the Royal Society B, 278, 801–809.
Levitis, D. A., & Martinez, D. E. (2013). The two halves of U-shaped mortality. Frontiers in Genetics, 4, 1–6.
Li, T., Yang, Y. C., & Anderson, J. J. (2013). Mortality increase in late-middle and early-old age: Heterogeneity in death processes as a new explanation. Demography, 50, 1563–1591.
Loudon, I. (1988). Maternal mortality: 1880–1950. Some regional and international comparisons. Social History of Medicine, 1, 183–228.
Luder, H. U. (1993). Onset of human aging estimated from hazard functions associated with various causes of death. Mechanisms of Ageing and Development, 67, 247–259.
Makeham, W. M. (1860). On the law of mortality and construction of annuity tables. Journal of the Institute of Actuaries, 13, 325–358.
Medawar, P. B. (1952). An unsolved problem in biology. London, UK: H.K. Lewis & Co.
Milne, E. M. G. (2006). When does human ageing begin? Mechanisms of Ageing and Development, 127, 290–297.
Missov, T. I. (2013). Gamma-Gompertz life expectancy at birth. Demographic Research, 28(article 9), 259–270. doi:10.4054/DemRes.2013.28.9
Olshansky, S. J., & Carnes, B. A. (1997). Ever since Gompertz. Demography, 34, 1–15.
Péron, G., Gimenez, O., Charmantier, A., Gaillard, J.-M., & Crochet, P.-A. (2010). Age at the onset of senescence in birds and mammals is predicted by early-life performance. Proceedings of the Royal Society B, 277, 2849–2856.
Rattan, S. I. S. (2006). Theories of biological aging: Genes, proteins, and free radicals. Free Radical Research, 40, 1230–1238.
Rattan, S. I. S. (2008). Increased molecular damage and heterogeneity as the basis of aging. Biological Chemistry, 389, 267–272.
Remund, A. (2012). Is young adult’s excess mortality a universal phenomenon? Unpublished manuscript, Catholic University of Louvain-la-Neuve, Belgium. Retrieved from http://www.uclouvain.be/cps/ucl/doc/demo/documents/RemundCQ.pdf
Shock, N. W. (1981). Indices of functional age. In D. Danon, N. W. Shock, & M. Marois (Eds.), Aging: A challenge to science and society (pp. 302–319). Oxford, UK: Oxford University Press.
Siler, W. (1979). A competing-risk model for animal mortality. Ecology, 60, 750–757.
Vaupel, J. (2003). Post-Darwinian longevity. In J. R. Carey & S. Tuljapurkar (Eds.), Life span: Evolutionary, ecological and demographic perspectives (Suppl. to Vol. 29, pp. 258–269). Population and Development Review. New York, NY: Population Council.
Vaupel, J. (2010). Biodemography of human ageing. Nature, 464, 536–542.
Vaupel, J., Manton, K., & Stallard, E. (1979). The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography, 16, 439–454.
Weale, R. A. (2004). Biorepair mechanisms and longevity. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 59, 449–454.
Williams, G. C. (1957). Pleiotropy, natural selection, and the evolution of senescence. Evolution, 11, 398–411.
Wrigley-Field, E. (2014). Mortality deceleration and mortality selection: Three unexpected implications of a simple model. Demography, 51, 51–71.
Yang, Y. (2008). Trends in U.S. adult chronic disease mortality, 1960–1999: Age, period and cohort variations. Demography, 45, 387–416.
Yin, D., & Chen, K. (2005). The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions. Experimental Gerontology, 40, 455–465.
Acknowledgment
The research work has been financed by the P.O.R. Sardinia F.S.E. 2007–2013 in the context of research project 13/D3-2 developed at the University of Sassari.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salinari, G., De Santis, G. On the Beginning of Mortality Acceleration. Demography 52, 39–60 (2015). https://doi.org/10.1007/s13524-014-0363-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13524-014-0363-0